171 related articles for article (PubMed ID: 11818207)
1. Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992.
van de Wouw AJ; Janssen-Heijnen ML; Coebergh JW; Hillen HF
Eur J Cancer; 2002 Feb; 38(3):409-13. PubMed ID: 11818207
[TBL] [Abstract][Full Text] [Related]
2. Unknown primary carcinoma in the Netherlands: decrease in incidence and survival times remain poor between 2000 and 2012.
Schroten-Loef C; Verhoeven RHA; de Hingh IHJT; van de Wouw AJ; van Laarhoven HWM; Lemmens VEPP
Eur J Cancer; 2018 Sep; 101():77-86. PubMed ID: 30031970
[TBL] [Abstract][Full Text] [Related]
3. Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown origin: favorable subsets of patients with unknown-primary carcinoma?
Lenzi R; Hess KR; Abbruzzese MC; Raber MN; Ordoñez NG; Abbruzzese JL
J Clin Oncol; 1997 May; 15(5):2056-66. PubMed ID: 9164218
[TBL] [Abstract][Full Text] [Related]
4. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
5. Population-based incidence, treatment and survival of patients with peritoneal metastases of unknown origin.
Thomassen I; Verhoeven RH; van Gestel YR; van de Wouw AJ; Lemmens VE; de Hingh IH
Eur J Cancer; 2014 Jan; 50(1):50-6. PubMed ID: 24011935
[TBL] [Abstract][Full Text] [Related]
6. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
7. Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands.
van der Sanden GA; Schouten LJ; van Dijck JA; van Andel JP; van der Maazen RW; Coebergh JW;
Cancer; 2002 Mar; 94(5):1548-56. PubMed ID: 11920513
[TBL] [Abstract][Full Text] [Related]
8. Melanoma of unknown primary origin: a population-based study in the Netherlands.
de Waal AC; Aben KK; van Rossum MM; Kiemeney LA
Eur J Cancer; 2013 Feb; 49(3):676-83. PubMed ID: 23031553
[TBL] [Abstract][Full Text] [Related]
9. Clinical and immunohistochemical analysis of patients with unknown primary tumour. A search for prognostic factors in UPT.
van de Wouw AJ; Jansen RL; Griffioen AW; Hillen HF
Anticancer Res; 2004; 24(1):297-301. PubMed ID: 15015611
[TBL] [Abstract][Full Text] [Related]
10. Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, Canada.
Kim CS; Hannouf MB; Sarma S; Rodrigues GB; Rogan PK; Mahmud SM; Winquist E; Brackstone M; Zaric GS
Acta Oncol; 2015 Nov; 54(10):1781-7. PubMed ID: 25825957
[TBL] [Abstract][Full Text] [Related]
11. Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961-2010.
Brewster DH; Lang J; Bhatti LA; Thomson CS; Oien KA
Cancer Epidemiol; 2014 Jun; 38(3):227-34. PubMed ID: 24726751
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of carcinoma of unknown primary in the head and neck.
Issing WJ; Taleban B; Tauber S
Eur Arch Otorhinolaryngol; 2003 Sep; 260(8):436-43. PubMed ID: 12684829
[TBL] [Abstract][Full Text] [Related]
13. The influence of comorbidities, age, and performance status on the prognosis and treatment of patients with metastatic carcinomas of unknown primary site: a population-based study.
Seve P; Sawyer M; Hanson J; Broussolle C; Dumontet C; Mackey JR
Cancer; 2006 May; 106(9):2058-66. PubMed ID: 16583433
[TBL] [Abstract][Full Text] [Related]
14. Survival of patients with synchronous brain metastases: an epidemiological study in southeastern Michigan.
Thomas AJ; Rock JP; Johnson CC; Weiss L; Jacobsen G; Rosenblum ML
J Neurosurg; 2000 Dec; 93(6):927-31. PubMed ID: 11117864
[TBL] [Abstract][Full Text] [Related]
15. Microvessel density in unknown primary tumors.
Hillen HF; Hak LE; Joosten-Achjanie SR; Arends JW
Int J Cancer; 1997 Feb; 74(1):81-5. PubMed ID: 9036874
[TBL] [Abstract][Full Text] [Related]
16. Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993.
Kerkhofs TM; Verhoeven RH; Van der Zwan JM; Dieleman J; Kerstens MN; Links TP; Van de Poll-Franse LV; Haak HR
Eur J Cancer; 2013 Jul; 49(11):2579-86. PubMed ID: 23561851
[TBL] [Abstract][Full Text] [Related]
17. Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin.
Abbruzzese JL; Abbruzzese MC; Lenzi R; Hess KR; Raber MN
J Clin Oncol; 1995 Aug; 13(8):2094-103. PubMed ID: 7636553
[TBL] [Abstract][Full Text] [Related]
18. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer.
van Gestel YR; Thomassen I; Lemmens VE; Pruijt JF; van Herk-Sukel MP; Rutten HJ; Creemers GJ; de Hingh IH
Eur J Surg Oncol; 2014 Aug; 40(8):963-9. PubMed ID: 24183168
[TBL] [Abstract][Full Text] [Related]
19. Incidence of primary malignant orbital tumours in the Netherlands.
Koopman JH; van der Heiden-van der Loo M; van Dijk MR; Bijlsma WR
Eye (Lond); 2011 Apr; 25(4):461-5. PubMed ID: 21336252
[TBL] [Abstract][Full Text] [Related]
20. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
